MODEL VERDICT
Cross Country Healthcare, Inc. (CCRN)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | MODERATE | 0.66 | $10.23 | CURRENT | — |
| Apr 24, 2026 | MODERATE | 0.66 | $10.06 | CURRENT | — |
| Apr 17, 2026 | MODERATE | 0.66 | $9.86 | CURRENT | — |
| Apr 16, 2026 | MODERATE | 0.66 | $10.04 | CURRENT | — |
| Apr 10, 2026 | MODERATE | 0.66 | $9.48 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Forward P/E 6 analyst estimates | $1.04 | -89.8% | 20% | A- | Analyst Est. |
| EV/EBITDA 5 industry peers | $7.61 | -25.6% | 20% | A- | Peer Data |
| Price / Free Cash Flow 5 industry peers | $12.63 | +23.5% | 15% | B+ | Peer Data |
| EV/FCF 5 industry peers | $20.82 | +103.5% | 7% | B | Model Driven |
| EV To Revenue 6 industry peers | $53.89 | +426.8% | 4% | B | Data |
| Price / Sales 6 industry peers | $44.49 | +334.9% | 3% | B | Model Driven |
| FCF Yield 5 industry peers | $6.93 | -32.3% | 1% | B | Data |
| Weighted Output Blended model output | $32.80 | +220.6% | 100% | 73 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/E Ratio | 8.07 | 7.86 | 5.29 | 11.04 | 2.88 |
| EV/EBIT | 20.35 | 8.49 | 4.30 | 57.52 | 22.19 |
| EV/EBITDA | 304.49 | 10.00 | 4.08 | 964.73 | 461.97 |
| P/FCF | 32.73 | 6.70 | 3.42 | 159.94 | 62.43 |
| P/FFO | 56.77 | 8.08 | 5.02 | 205.90 | 99.43 |
| P/TBV | 9.74 | 4.00 | 1.13 | 35.95 | 12.34 |
| P/AFFO | 7.81 | 7.73 | 5.26 | 10.43 | 2.59 |
| P/B Ratio | 2.03 | 2.07 | 0.81 | 3.49 | 0.85 |
| P/S Ratio | 0.42 | 0.40 | 0.25 | 0.62 | 0.12 |
Based on our peer multiples analysis with 18 valuation metrics, the model estimates CCRN's fair value at $32.80 vs the current price of $10.23, implying +220.6% upside potential. Model verdict: Significantly Undervalued. Confidence: 73/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $32.80 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $12.03 (P10) to $64.47 (P90), with a median of $32.20.
CCRN's current P/E of -3.5x compares to the industry median of 17.4x (3 peers in the group). This represents a -120.0% discount to the industry. The historical average P/E is 8.1x over 3 years. Signal: Deep Discount.
14 analysts cover CCRN with a consensus rating of Hold. The consensus price target is $10.61 (range: $8.65 — $14.00), implying +3.7% upside from the current price. Grade breakdown: Strong Buy (0), Buy (4), Hold (10), Sell (0), Strong Sell (0).
The model confidence score is 73/100, based on: data completeness (18), peer quality (25), historical depth (20), earnings stability (8), and model agreement (2). Cyclicality penalty: -0 points. The model shows strong agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for CCRN.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.